Compare QGEN & NYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QGEN | NYT |
|---|---|---|
| Founded | 1986 | 1851 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Newspapers/Magazines |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 11.4B |
| IPO Year | 1996 | N/A |
| Metric | QGEN | NYT |
|---|---|---|
| Price | $45.08 | $69.46 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 6 |
| Target Price | $50.07 | ★ $65.33 |
| AVG Volume (30 Days) | 1.1M | ★ 1.7M |
| Earning Date | 02-04-2026 | 02-04-2026 |
| Dividend Yield | ★ 3.36% | 1.04% |
| EPS Growth | ★ 331.20 | 21.46 |
| EPS | 1.84 | ★ 2.05 |
| Revenue | $2,070,781,000.00 | ★ $2,722,033,000.00 |
| Revenue This Year | $7.07 | $11.06 |
| Revenue Next Year | $6.14 | $6.93 |
| P/E Ratio | ★ $24.46 | $33.84 |
| Revenue Growth | 5.32 | ★ 8.49 |
| 52 Week Low | $37.63 | $44.83 |
| 52 Week High | $51.88 | $71.23 |
| Indicator | QGEN | NYT |
|---|---|---|
| Relative Strength Index (RSI) | 42.69 | 62.91 |
| Support Level | $45.13 | $69.27 |
| Resistance Level | $46.02 | $71.23 |
| Average True Range (ATR) | 0.61 | 0.99 |
| MACD | -0.04 | -0.21 |
| Stochastic Oscillator | 29.34 | 59.17 |
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as NYTimes and various smartphone applications. The company has two segments: New York Times Group and The Athletic. The company generates the majority of its revenue from the NYTG segment. The NYTG and The Athletic segments derive revenue from subscriptions, Advertising, and others, where the majority source of revenue for both segments is subscription.